As­traZeneca pays out $425M to set­tle lit­i­ga­tion over Prilosec and Nex­i­um but ad­mits no wrong­do­ing

As­traZeneca has agreed to pay out $425 mil­lion to set­tle thou­sands of com­bined law­suits filed against the com­pa­ny over acid re­flux med­i­cine Nex­i­um and heart­burn drug Prilosec, the com­pa­ny said Tues­day.

The agree­ments “ef­fec­tive­ly re­solve” the cas­es that were pend­ing in sev­er­al courts: the US Dis­trict Court for the Dis­trict of New Jer­sey, the Delaware Su­pe­ri­or Court and the New Jer­sey Su­pe­ri­or Court. The law­suits al­leged that As­traZeneca did not do enough to warn pa­tients and doc­tors about the risk of con­tract­ing chron­ic kid­ney dis­ease and oth­er re­lat­ed is­sues from long-term use of the pre­scrip­tion-on­ly med­i­cines, and that the com­pa­nies con­cealed the risks of the med­ica­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.